← FDA Drug Approvals (Drugs@FDA)

IRINOTECAN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARM HAINAN · Approved 2016-05-03

Drug application

FDA Application #
ANDA203380
Application type
Abbreviated New Drug Application (Generic)
Brand name
IRINOTECAN HYDROCHLORIDE
Generic name
IRINOTECAN HYDROCHLORIDE
Active ingredients
IRINOTECAN HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
QILU PHARM HAINAN
Manufacturer
Apotex Corp.
First approval
2016-05-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown